1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Patente
  4. Patente Life Sciences und Facility Management
Full metadata record
DC FieldValueLanguage
dc.contributor.otherWeichert, Andreas Gerhard-
dc.contributor.otherBarrett, David Gene-
dc.contributor.otherHeuser, Stefan-
dc.contributor.otherRiedl, Rainer-
dc.contributor.otherTebbe, Mark Joseph-
dc.contributor.otherZaliani, Andrea-
dc.date.accessioned2019-05-06T10:07:52Z-
dc.date.available2019-05-06T10:07:52Z-
dc.date.issued2011-04-20-
dc.date.submitted2003-12-16-
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/17040-
dc.identifier.urihttps://worldwide.espacenet.com/patent/search?q=pn%3DEP1585739B1de_CH
dc.description.sponsorshipEli Lilly and Companyde_CH
dc.language.isoende_CH
dc.subjectOrganic synthesisde_CH
dc.subjectMedicinal chemistryde_CH
dc.subjectGlucokinase activatorde_CH
dc.subject.ddc540: Chemiede_CH
dc.titleSubstituted arylcyclopropylacetamides as glucokinase activatorsde_CH
dc.title.alternativeSubstituierte Arylcyclopropylacetamide als Glucokinaseaktivatorende_CH
dc.title.alternativeArylcyclopropylacetamides substitues servant d'activateurs de glucokinasede_CH
dc.typePatentde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
zhaw.funding.euNode_CH
zhaw.originated.zhawYesde_CH
zhaw.id.patentEP1585739de_CH
zhaw.publication.codeB1de_CH
zhaw.display.portraitYesde_CH
zhaw.relation.patentAT506354Tde_CH
zhaw.relation.patentAU2003297291A1de_CH
zhaw.relation.patentCA2509086A1de_CH
zhaw.relation.patentCA2509086Cde_CH
zhaw.relation.patentCY1111481T1de_CH
zhaw.relation.patentDK1585739T3de_CH
zhaw.relation.patentES2362656T3de_CH
zhaw.relation.patentJP2006515858Ade_CH
zhaw.relation.patentJP4716734B2de_CH
zhaw.relation.patentPT1585739Ede_CH
zhaw.relation.patentSI1585739T1de_CH
zhaw.relation.patentUS2006111353A1de_CH
zhaw.relation.patentUS7576108B2de_CH
zhaw.relation.patentWO2004063179A1de_CH
Appears in collections:Patente Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.
Show simple item record
Weichert, A. G., Barrett, D. G., Heuser, S., Riedl, R., Tebbe, M. J., & Zaliani, A. (2011). Substituted arylcyclopropylacetamides as glucokinase activators (Patent No. EP1585739B1). https://worldwide.espacenet.com/patent/search?q=pn%3DEP1585739B1
Weichert, A.G. et al. (2011) ‘Substituted arylcyclopropylacetamides as glucokinase activators’. Available at: https://worldwide.espacenet.com/patent/search?q=pn%3DEP1585739B1.
A. G. Weichert, D. G. Barrett, S. Heuser, R. Riedl, M. J. Tebbe, and A. Zaliani, “Substituted arylcyclopropylacetamides as glucokinase activators,” EP1585739B1, Apr. 20, 2011 [Online]. Available: https://worldwide.espacenet.com/patent/search?q=pn%3DEP1585739B1
WEICHERT, Andreas Gerhard, David Gene BARRETT, Stefan HEUSER, Rainer RIEDL, Mark Joseph TEBBE und Andrea ZALIANI, 2011. Substituted arylcyclopropylacetamides as glucokinase activators [online]. EP1585739B1. 20 April 2011. Verfügbar unter: https://worldwide.espacenet.com/patent/search?q=pn%3DEP1585739B1
Weichert, Andreas Gerhard, David Gene Barrett, Stefan Heuser, Rainer Riedl, Mark Joseph Tebbe, and Andrea Zaliani. 2011. Substituted arylcyclopropylacetamides as glucokinase activators. EP1585739B1, filed December 16, 2003, and issued April 20, 2011. https://worldwide.espacenet.com/patent/search?q=pn%3DEP1585739B1.
Weichert, Andreas Gerhard, et al. Substituted Arylcyclopropylacetamides as Glucokinase Activators. EP1585739B1, 20 Apr. 2011, https://worldwide.espacenet.com/patent/search?q=pn%3DEP1585739B1.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.